-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Jiangsu Fish Leap Medical Equipment Co., Ltd. ("Company" or "Fish Leap Medical", share code: 002223) announced that the company intends to invest 200 million yuan of its own capital as a limited partner to set up AstraZeneone Medical Venture Capital Partnership (Limited Partnership).
the size of the partnership of up to 2.5 billion yuan, paid by AstraZeneta and COFKIN Capital and other partners. according to the
announcement, the partnership will achieve capital appreciation by directly or indirectly (including, but not limited to, indirect investments made through investments in regional funds) equity, quasi-equity or other investments or investment-related activities of unlisted or listed enterprises primarily related to the medical and health industry in China.
comes after AstraZeneone reached its first strategic partnership with Fish Leap Healthcare in June to explore sustainable, disease-wide management business models in the areas of respiratory, cardiovascular and oncology.
.
